Highlights from Cubist Pharma CBST earnings call regarding various topics. Conference call excerpts via SeekingAlpha. Note some of these assets originate from the acquisition of Adolor ADLR.
The two key products that Cubist $CBST acquired in their buyout of Adolor $ADLR got more attention from analysts on Cubist's recent 2q-2012 earnings call than they seemingly ever did when Adolor was an independent company.
Continue reading below, and find historical context and info here.
Also be sure to check out coverage of Cubist by Jason Chew at Chimera Research.
Your support is greatly appreciated